Fda - Articles - Page 22 | Food Engineering

Regulatory Watch

FDA amends carcinogenicity testing requirements

Updated regulations eliminate requirement that a sponsor conduct oral, chronic, dose-type studies.

July 27, 2017

The Food and Drug Administration is amending the regulations governing carcinogenicity testing requirements for food-producing animals.

Regulatory Watch

FDA allows DUNS number as facility identifier

DUNS number can be used to meet FSVP requirements

June 26, 2017

FDA has formally recognized the Data Universal Number System (DUNS) number as an acceptable unique facility identifier (UFI) for importers under the Foreign Supplier Verification Programs (FSVP) rule.

Food Safety

What you need to know before an FDA visit

What your company needs to properly develop, document and implement before an investigation

Richard F. Stier

June 15, 2017

To ensure an FDA inspection is handled properly, it is imperative procedures are in place to do so.

Regulatory Watch

FDA issues revised guidance for genetically altered animals

The guidance deals with animals whose genomes have been intentionally altered.

April 19, 2017

The guidance applies to both the originally altered animal and its lineage.

FDA Commissioner

Gottlieb expected to focus on drug side of FDA

Medical background, experience plays major role in commissioner nomination

Casey Laughman

March 28, 2017

Dr. Scott Gottlieb will be taking over as FDA commissioner at an interesting time.

Manufacturing News

GAO evaluates FDA on Produce Safety Rule communications

The rule includes many provisions that have raised many technical and business questions.

January 29, 2017

While the rule establishes enforceable national standards for the on-farm growing, harvesting and holding of domestic and imported produce, it also includes many other provisions that have raised many technical and business questions.

Regulatory Watch

FSIS announces companies can use new FDA label format for now

The FSIS will not hold companies in noncompliance if they use the FDA label during the rulemaking period as long as the information is truthful and not misleading.

December 22, 2016

The FSIS will not hold companies in noncompliance if they use the FDA label during the rulemaking period as long as the information is truthful and not misleading.